Antimicrobial resistance (AMR) is a growing threat to global health. The EU follows a “One Health” approach to the problem, considering veterinary, human health, and environmental issues. We examined how the Commission and relevant EU agencies managed their support to Member States and the EU funded research aimed at fighting antimicrobial resistance. We concluded that the activities of the Commission and agencies led to some progress. However, there is little evidence that the health burden of AMR has reduced. We make recommendations to improve the Commission’s response to AMR through better support to Member State national action plans; promoting better monitoring and the prudent use of antimicrobials; and strengthening strategies for boosting research.
ECA special report pursuant to Article 287(4), second subparagraph, TFEU.
Special report No 21/2019: Addressing antimicrobial resistance: progress in the animal sector, but this health threat remains a challenge for the EU